37 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
Rank Status Study
21 Not yet recruiting Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: ticagrelor
22 Not yet recruiting Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Conditions: Arterial Occlusive Diseases;   Coronary Artery Disease;   Coronary Disease;   Arteriosclerosis;   Heart Diseases;   Myocardial Ischemia;   Vascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: PZ-128;   Drug: Placebo
23 Recruiting Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
Conditions: Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions: Drug: Aspirin + clopidogrel;   Drug: Aspirin monotherapy;   Drug: OAC + clopicogrel;   Drug: OAC monotherapy
24 Recruiting Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
25 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol
26 Recruiting Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
Condition: Coronary Artery Disease
Interventions: Drug: Prasugrel;   Drug: Ticagrelor
27 Recruiting Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin
Condition: Coronary Artery Disease
Interventions: Drug: Cloas;   Drug: Plavix/Astrix
28 Unknown  The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Conditions: Hypercholesterolemia;   Thrombosis
Interventions: Drug: Clopidogrel;   Drug: Atorvastatin
29 Unknown  Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
Conditions: Diabetes Mellitus;   Coronary Disease
Interventions: Drug: Ticagrelor;   Drug: Continued clopidogrel
30 Recruiting Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
Conditions: Coronary Artery Disease;   Stable Angina;   Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: Aspirin;   Drug: Placebo - Ticagrelor;   Drug: Placebo - Aspirin
31 Recruiting Sexual Hormones and Haemostasis: Observations for Women Health
Conditions: Gender;   Sex
32 Recruiting Effect of Ticagrelor on Endothelial Function
Conditions: Coronary Artery Disease;   Endothelial Function
Interventions: Drug: clopidogrel;   Drug: Ticagrelor
33 Unknown  Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
Condition: Chronic Kidney Disease
Interventions: Drug: Aspirin;   Drug: Clopidogrel
34 Unknown  Study of LC23-1306 in Healthy Male Subjects
Condition: Acute Coronary Syndrome
Interventions: Drug: LC23-1306;   Drug: placebo;   Drug: Ticagrelor
35 Unknown  Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Conditions: Coronary Artery Disease;   Myocardial Ischemia;   Bleeding
Intervention: Drug: clopidogrel 600 mg
36 Recruiting Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?
Condition: Acute Coronary Syndome
Interventions: Other: Blood Test;   Other: EndoPAT - endothelial assessment
37 Recruiting The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry
Condition: Platelet Aggregation Onhibitors
Intervention: Drug: antiplatelet drugs - P2Y12 antagonists

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years